Dismissal of Humira US antitrust case backed by law, economics professors
MLex Summary: Plaintiffs seeking to revive US antitrust claims against AbbVie, Amgen, Samsung Bioepis and Sandoz over generic Humira are seeking to disregard existing law by expanding antitrust liability to cover...To view the full article, register now.
Already a subscriber? Click here to view full article